1987•Drug and Therapeutics BulletinRequires access

Stopping drug treatment in schizophrenia

Author information unavailable

Open publisher page 0 citations

Abstract

Patients with schizophrenic illnesses often fail to make a full recovery. Only about 25% of patients in western countries remain symptom-free after recovery from a first episode of acute schizophrenia.1–3 Antipsychotic medication suppresses symptoms and reduces the frequency of relapse, but the continuing underlying illness will cause many schizophrenics to relapse when these drugs are stopped. This article assesses the long-term benefits and risks of continuing or discontinuing antipsychotic therapy for schizophrenia.

About this research paper

What this paper is about

Patients with schizophrenic illnesses often fail to make a full recovery. Only about 25% of patients in western countries remain symptom-free after recovery from a first episode of acute schizophrenia.1–3 Antipsychotic medication suppresses symptoms and reduces the frequency of relapse, but the continuing underlying illness will cause many schizophrenics to relapse when these drugs are stopped. This article assesses the long-term benefits and risks of continuing or discontinuing antipsychotic therapy for schizophrenia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Patients with schizophrenic illnesses often fail to make a full recovery. Only about 25% of patients in western countries remain symptom-free after recovery from a first episode of acute schizophrenia.1–3 Antipsychotic medication suppresses symptoms and reduces the frequency of relapse, but the continuing underlying illness will cause many schizophrenics to relapse when these drugs are stopped. This article assesses the long-term benefits and risks of continuing or discontinuing antipsychotic therapy for schizophrenia.

Key concepts: Schizophrenia (object-oriented programming), Psychiatry, Antipsychotic, Antipsychotic drug, Medicine, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Stopping drug treatment in schizophrenia — Research Paper | ScholarLens